116 related articles for article (PubMed ID: 21165953)
1. Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma.
Chan KC; Ko JM; Lung HL; Sedlacek R; Zhang ZF; Luo DZ; Feng ZB; Chen S; Chen H; Chan KW; Tsao SW; Chua DT; Zabarovsky ER; Stanbridge EJ; Lung ML
Int J Cancer; 2011 Oct; 129(8):1826-37. PubMed ID: 21165953
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
[TBL] [Abstract][Full Text] [Related]
3. Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.
Zhang H; Feng X; Liu W; Jiang X; Shan W; Huang C; Yi H; Zhu B; Zhou W; Wang L; Liu C; Zhang L; Jia W; Huang W; Li G; Shi J; Wanggou S; Yao K; Ren C
J Cell Biochem; 2011 Jul; 112(7):1832-43. PubMed ID: 21400573
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma.
Law EW; Cheung AK; Kashuba VI; Pavlova TV; Zabarovsky ER; Lung HL; Cheng Y; Chua D; Lai-Wan Kwong D; Tsao SW; Sasaki T; Stanbridge EJ; Lung ML
Oncogene; 2012 Feb; 31(6):728-38. PubMed ID: 21743496
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.
Cheung AK; Lung HL; Ko JM; Cheng Y; Stanbridge EJ; Zabarovsky ER; Nicholls JM; Chua D; Tsao SW; Guan XY; Lung ML
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14478-83. PubMed ID: 19667180
[TBL] [Abstract][Full Text] [Related]
6. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma.
Lung HL; Cheung AK; Xie D; Cheng Y; Kwong FM; Murakami Y; Guan XY; Sham JS; Chua D; Protopopov AI; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2006 Oct; 66(19):9385-92. PubMed ID: 17018592
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma.
Feng X; Ren C; Zhou W; Liu W; Zeng L; Li G; Wang L; Li M; Zhu B; Yao K; Jiang X
Mol Carcinog; 2014 Nov; 53(11):858-70. PubMed ID: 23908159
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.
Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573
[TBL] [Abstract][Full Text] [Related]
9. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
10. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis.
Ming H; Lan Y; He F; Xiao X; Zhou X; Zhang Z; Li P; Huang G
Chin J Cancer; 2015 Aug; 34(10):459-67. PubMed ID: 26275421
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
13. DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells.
Feng X; Li C; Liu W; Chen H; Zhou W; Wang L; Zhu B; Yao K; Jiang X; Ren C
Int J Oncol; 2013 Jun; 42(6):1973-84. PubMed ID: 23588806
[TBL] [Abstract][Full Text] [Related]
14. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma.
Yau WL; Lung HL; Zabarovsky ER; Lerman MI; Sham JS; Chua DT; Tsao SW; Stanbridge EJ; Lung ML
Int J Cancer; 2006 Dec; 119(12):2821-6. PubMed ID: 16929489
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma.
Yang Z; Lan H; Chen X; Li P; Li S; Mo W; Tang A
Neoplasma; 2014; 61(2):170-6. PubMed ID: 24299313
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma].
Liu XQ; Pan ZG; Li MZ; Jiang JH; Fu J; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Feb; 22(2):128-35. PubMed ID: 12600284
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma.
Lung HL; Lo PHY; Xie D; Apte SS; Cheung AKL; Cheng Y; Law EWL; Chua D; Zeng YX; Tsao SW; Stanbridge EJ; Lung ML
Int J Cancer; 2008 Jul; 123(2):401-408. PubMed ID: 18449890
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
Yang EV; Sood AK; Chen M; Li Y; Eubank TD; Marsh CB; Jewell S; Flavahan NA; Morrison C; Yeh PE; Lemeshow S; Glaser R
Cancer Res; 2006 Nov; 66(21):10357-64. PubMed ID: 17079456
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
Wong VC; Chen H; Ko JM; Chan KW; Chan YP; Law S; Chua D; Kwong DL; Lung HL; Srivastava G; Tang JC; Tsao SW; Zabarovsky ER; Stanbridge EJ; Lung ML
Int J Cancer; 2012 Jan; 130(1):83-95. PubMed ID: 21387288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
